Orange Book product · Brand (NDA)
LUXIQ
BETAMETHASONE VALERATE
At a glance
Feb 28, 1999
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Feb 28, 1999
27 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
BETAMETHASONE VALERATE
Strength
0.12% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage form
AEROSOL, FOAM
Route
TOPICAL
TE code
Not listed
Application
NDA 020934
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 1983BETAMETHASONE VALERATEBrand (NDA)
NDA 018861 · FOUGERA PHARMS INC
- 1983BETAMETHASONE VALERATEBrand (NDA)
NDA 018860 · PHARMADERM
- 1983BETATREXBrand (NDA)
NDA 018862 · SAVAGE LABS
- 1983BETAMETHASONE VALERATEBrand (NDA)
NDA 018866 · FOUGERA PHARMS INC
- 1983BETAMETHASONE VALERATEBrand (NDA)
NDA 018870 · PHARMADERM
- 1983BETATREXBrand (NDA)
NDA 018867 · SAVAGE LABS
- 1983BETAMETHASONE VALERATEBrand (NDA)
NDA 018865 · FOUGERA PHARMS INC
- 1983BETAMETHASONE VALERATEBrand (NDA)
NDA 018864 · PHARMADERM
- 1983BETATREXBrand (NDA)
NDA 018863 · SAVAGE LABS
- 1983BETADERMBrand (NDA)
NDA 018839 · ROACO
- 1983BETA-VALBrand (NDA)
NDA 018642 · COSETTE PHARMS NC
- —VALISONEBrand (NDA)
NDA 016322 · SCHERING
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
